Hans Jeppsson
Direttore Finanziario/CFO presso VICORE PHARMA HOLDING AB
Patrimonio netto: 8 227 $ in data 30/04/2024
Posizioni attive di Hans Jeppsson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VICORE PHARMA HOLDING AB | Direttore Finanziario/CFO | 01/01/2017 | - |
| Public Communications Contact | 01/01/2017 | - | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | - | - |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hans Jeppsson
Precedenti posizioni note di Hans Jeppsson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Danske Bank A/S (Sweden) | Analyst-Equity | - | - |
Formazione di Hans Jeppsson
| University of Gothenburg | Doctorate Degree |
| Handelshögskolan i Göteborg | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svezia | 7 |
Posizioni
| Doctorate Degree | 2 |
| Graduate Degree | 2 |
| Analyst-Equity | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VICORE PHARMA HOLDING AB | Health Technology |
| Aziende private | 3 |
|---|---|
| Danske Bank A/S (Sweden) | Finance |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
INIM Pharma AB
INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Hans Jeppsson
- Esperienza
